FalavarjaniKGNguyenQD.Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye2013; 27(7): 787–794.
2.
GrzybowskiAToldRSacuS, et al. Update on intravitreal injections: euretina expert consensus recommendations. Ophthalmologica2018; 239(4): 181–93.
3.
AveryRLBakriSJBlumenkranzMS, et al. Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina2014;34(Suppl 12):S1–S18.
4.
MandalKAdamsWFraserS.“Near misses” in a cataract theatre: how do we improve understanding and documentation?Br J Ophthalmol2005;89(12):1565–1568.
5.
KellySPBaruaA.A review of safety incidents in England and Wales for vascular endothelial growth factor inhibitor medications. Eye2011; 25(6): 710–716.
